Wed, January 13, 2021
Tue, January 12, 2021
Mon, January 11, 2021
Sun, January 10, 2021
Fri, January 8, 2021
Thu, January 7, 2021
Wed, January 6, 2021
Tue, January 5, 2021

Matthew Harrison Downgraded (SRPT) to Hold and Decreased Target to $95 on, Jan 8th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -and-decreased-target-to-95-on-jan-8th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Harrison of Morgan Stanley, Downgraded "Sarepta Therapeutics, Inc." (SRPT) to Hold and Decreased Target from $182 to $95 on, Jan 8th, 2021.

Matthew has made no other calls on SRPT in the last 4 months.



There are 2 other peers that have a rating on SRPT. Out of the 2 peers that are also analyzing SRPT, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Matthew


  • Colin Bristow of "UBS" Initiated at Strong Buy and Held Target at $212 on, Wednesday, October 28th, 2020
  • Joel Beatty of "Citigroup" Maintained at Strong Buy with Increased Target to $190 on, Tuesday, September 15th, 2020

Publication Contributing Sources